Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Matching the right drug to the right patient in essential hypertension.

× No keyword cloud information.

37 in total

1. Potentially high prevalence of primary aldosteronism in a primary-care population.

Authors: P O Lim; P Rodgers; K Cardale; A D Watson; T M MacDonald
Journal: Lancet Date: 1999-01-02 Impact factor: 79.321

2. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors: S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245

3. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors: S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal: Circulation Date: 1999-07-27 Impact factor: 29.690

4. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.

Authors: D S Geller; A Farhi; N Pinkerton; M Fradley; M Moritz; A Spitzer; G Meinke; F T Tsai; P B Sigler; R P Lifton
Journal: Science Date: 2000-07-07 Impact factor: 47.728

5. Optimisation of antihypertensive treatment by crossover rotation of four major classes.

Authors: J E Dickerson; A D Hingorani; M J Ashby; C R Palmer; M J Brown
Journal: Lancet Date: 1999-06-12 Impact factor: 79.321

6. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine.

Authors: S Attwood; R Bird; K Burch; B Casadei; A Coats; J Conway; M Dawes; D Ebbs; A Farmer; J Robinson
Journal: J Hypertens Date: 1994-09 Impact factor: 4.844

7. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors: R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal: Nature Date: 1992-01-16 Impact factor: 49.962

8. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene.

Authors: P M Stewart; Z S Krozowski; A Gupta; D V Milford; A J Howie; M C Sheppard; C B Whorwood
Journal: Lancet Date: 1996-01-13 Impact factor: 79.321

9. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel.

Authors: R A Shimkets; D G Warnock; C M Bositis; C Nelson-Williams; J H Hansson; M Schambelan; J R Gill; S Ulick; R V Milora; J W Findling
Journal: Cell Date: 1994-11-04 Impact factor: 41.582

4. Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy.

Authors: Waymon Drummond; Mark A Munger; Mohammed Rafique Essop; Mojdeh Maboudian; Mahmudul Khan; Deborah L Keefe
Journal: J Clin Hypertens (Greenwich) Date: 2007-10 Impact factor: 3.738

4 in total

Matching the right drug to the right patient in essential hypertension.